If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptima Health Regulatory News (OPT)

Share Price Information for Optima Health (OPT)

Share Price is delayed by 15 minutes
Get Live Data
191.00    0.00 (0.00%)
Bid:
190.00
Ask:
192.00
Spread: 2.00 (1.053%)
Market Cap: £207.76m
OPT Live PriceLast checked at - London Stock Exchange

Intraday Optima Health Share Chart

NASDAQ Audit Committee Rule Non-Compliance

24 Oct 2008 15:27

RNS Number : 6685G
Ocean Power Technologies Inc
24 October 2008
 



Ocean Power Technologies, Inc.

1590 Reed Road

PenningtonNew Jersey 08534

USA

For Immediate Release October 24, 2008

Nasdaq AudiT Committee Rule non-compliance

Ocean Power Technologies, Inc. (Nasdaq: OPTT and London Stock Exchange AIM: OPT) ("OPT" or the "Company") announces today that it has received a Nasdaq Staff Deficiency Letter dated October 21, 2008 indicating that the Company does not currently comply with Marketplace Rule 4350 (d) (2). This Rule provides that the audit committee of a Nasdaq-listed company have at least three members, each of whom is independent and meets certain other specified criteria. Sir Eric A. Ash did not stand for re-election to the Company's board of directors at the annual meeting held on October 2, 2008, and he has not at the present time been replaced on the audit committee, which currently has two independent directors. Consistent with Marketplace Rule 4350 (d) (4), the Company has been provided a "cure period" until the earlier of its next annual meeting or September 28, 2009 to regain compliance.  The Company will be in full compliance with the Marketplace Rules within the cure period.

Forward-Looking Statements

This release may contain "forward-looking statements" that are within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect the Company's current expectations about its future plans and performance, including statements concerning the impact of marketing strategies, new product introductions and innovation, deliveries of product, sales, earnings, and margins. These forward-looking statements rely on a number of assumptions and estimates which could be inaccurate and which are subject to risks and uncertainties. Actual results could vary materially from those anticipated or expressed in any forward-looking statement made by the Company. Please refer to the Company's most recent Form 10-K for a further discussion of these risks and uncertainties. The Company disclaims any obligation or intent to update the forward-looking statements in order to reflect events or circumstances after the date of this release.

  About Ocean Power Technologies

Ocean Power Technologies (Nasdaq: OPTT and London Stock Exchange AIM: OPT) is a pioneer in wave-energy technology that harnesses ocean wave resources to generate reliable, clean, and environmentally-beneficial electricityOPT has a strong track record in harnessing wave energy and participates in a $150 billion renewable energy market. The Company's proprietary PowerBuoy® system is based on modular, ocean-going buoys that capture and converts predictable wave energy into low-cost, clean electricityThe Company is widely recognized as the leading provider of on-grid and autonomous wave-energy generation with its energy systems benefiting from over a decade of in-ocean experience. OPT's technology and systems are insured by Lloyds Underwriters of London. OPT is headquartered in PenningtonNew Jersey with offices in WarwickUK. More information can be found at www.oceanpowertechnologies.com.

Contact information:

Ocean Power Technologies, Inc.

Dr. George W. Taylor, Chief Executive Officer

Charles F. Dunleavy, Chief Financial Officer 

Telephone: +1 609 730 0400

Telephone: +1 609 730 0400

Media Contact in United States:

Edelman 

Mona J. Walsh

Media Contact in United Kingdom

Corfin Communications 

Neil Thapar, Martin Sutton

Collins Stewart Europe Limited

Adrian Hadden 

Telephone: +1212 704 4598

Email: mona.walsh@edelman.com 

Telephone: +44 20 7977 0020

Telephone: +44 20 7523 8350

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPUGQPUUPRGCC
Date   Source Headline
23rd Jun 20269:10 amRNSHolding(s) in Company
16th Jun 20267:00 amRNSFull Year Trading Update
10th Jun 202611:46 amRNSHolding(s) in Company
9th Jun 20269:27 amRNSHolding(s) in Company
29th May 20268:34 amRNSHolding(s) in Company
27th May 202612:40 pmRNSHolding(s) in Company
18th May 202610:51 amRNSHolding(s) in Company
13th May 202612:12 pmRNSHolding(s) in Company
12th May 20265:32 pmRNSHolding(s) in Company
12th May 20261:00 pmRNSHolding(s) in Company
5th May 202610:22 amRNSHolding(s) in Company
5th May 20268:58 amRNSHolding(s) in Company
30th Apr 20263:36 pmRNSHolding(s) in Company
29th Apr 20266:02 pmRNSHolding(s) in Company
28th Apr 202610:39 amRNSHolding(s) in Company
28th Apr 20267:00 amRNSDirector/PDMR Shareholding
27th Apr 20264:27 pmRNSHolding(s) in Company
27th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 20263:57 pmRNSResult of GM and Underwritten Open Offer
17th Apr 20267:00 amRNSFull Year Trading Update
31st Mar 20267:00 amRNSLaunch of Underwritten Open Offer
30th Mar 20263:20 pmRNSHolding(s) in Company
24th Mar 20264:37 pmRNSIrish FDI Clearance & Expected Acquisition of PAM
23rd Mar 20267:00 amRNSDirectorate Change
12th Mar 20264:04 pmRNSHolding(s) in Company- Replacement
12th Mar 20267:00 amRNSContract Win
12th Mar 20267:00 amRNSContract Win
5th Mar 20263:50 pmRNSHolding(s) in Company
4th Mar 20263:33 pmRNSHolding(s) in Company
24th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Feb 20267:00 amRNSAppointment of Joint Broker
16th Feb 20267:00 amRNSAcquisition of PAM Healthcare Limited
9th Feb 20269:04 amRNSHolding(s) in Company
2nd Feb 20264:26 pmRNSHolding(s) in Company
10th Dec 20257:00 amRNSInterim Results
13th Nov 20257:00 amRNSNotice of Half Year Results
6th Nov 20252:17 pmRNSHolding(s) in Company
3rd Nov 20255:14 pmRNSHolding(s) in Company
3rd Nov 202511:15 amRNSHolding(s) in Company
3rd Nov 20257:00 amRNSHalf Year Trading Update
31st Oct 20252:00 pmRNSHolding(s) in Company
31st Oct 202511:06 amRNSHolding(s) in Company
20th Oct 20254:35 pmRNSHolding(s) in Company
29th Sep 20252:06 pmRNSHolding(s) in Company
23rd Sep 20257:00 amRNS-ROptima Health launches Optima Health Ireland
1st Sep 20254:06 pmRNSResult of AGM
4th Aug 202510:31 amRNSHolding(s) in Company
1st Aug 20252:55 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSNotice of AGM and posting of Annual Report
14th Jul 20253:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.